Author Response to “Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease and Colorectal Carcinomas”

• Cardiovascular
• Aspirin
• Colorectal carcinomas
• Primary prevention

Editor – We appreciate your interest in our article published in Clinical Medicine & Research.¹ Since the guidelines were published in a cardiology journal, we felt it would be beneficial to clarify and discuss the recommendations in an internal medicine journal. Primary care providers are the front lines to guide their patients regarding aspirin use for primary prevention. Our discussion started from the studies published in the early 1980’s for secondary prevention and ended with the most recent primary prevention studies. The conclusions hopefully provide a clear guide to clinicians to be able to provide the best care for their patients. The article focuses on aspirin use for cardiovascular disease only. Thank you again for your interest.

• Received November 18, 2020.
• Accepted December 9, 2020.